BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 12656653)

  • 1. Barrett's oesophagus: optimal strategies for prevention and treatment.
    Fass R; Sampliner RE
    Drugs; 2003; 63(6):555-64. PubMed ID: 12656653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Med J Aust; 2004 Apr; 180(8):387-91. PubMed ID: 15089728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid suppression and surgical therapy for Barrett's oesophagus.
    de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antireflux surgery for Barrett's oesophagus.
    Lord RV
    ANZ J Surg; 2003 Apr; 73(4):234-6. PubMed ID: 12662234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.
    Fitzgerald RC; Lascar R; Triadafilopoulos G
    Aliment Pharmacol Ther; 2001 Mar; 15(3):269-76. PubMed ID: 11207503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endoscopic treatment of Barrett's oesophagus].
    Boyer J
    Ann Chir; 2006 Jan; 131(1):7-11. PubMed ID: 16376846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: screening and surveillance of Barrett's oesophagus: what is a cost-effective framework?
    Spechler SJ; Barr H
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():49-53. PubMed ID: 14725579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's oesophagus: a review of costs of the illness.
    Arguedas MR; Eloubeidi MA
    Pharmacoeconomics; 2001; 19(10):1003-11. PubMed ID: 11735670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
    Falk GW
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):125-38. PubMed ID: 25743461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
    Mayne GC; Bright T; Hussey DJ; Watson DI
    ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.
    Roman S; Kahrilas PJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):17-28. PubMed ID: 25743453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.